Koers Generex Biotechnology Corporation OTC Bulletin Board
Aandelen
US3714851033
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
2022 | Onvrijwillig verzoekschrift goedgekeurd voor Generex Biotechnology Corporation | CI |
2022 | Onvrijwillig verzoekschrift ingediend tegen Generex Biotechnology Corporation | CI |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 21-11-17 |
Mark Carrao
DFI | Director of Finance/CFO | - | 01-01-17 |
Terry Thompson
COO | Chief Operating Officer | 65 | 25-06-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Brian T. McGee
BRD | Director/Board Member | 63 | 01-03-04 |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 01-01-05 |
Craig Eagle
BRD | Director/Board Member | 57 | 21-11-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,72% | 125 mld. | |
+14,19% | 108 mld. | |
-4,93% | 24,21 mld. | |
+3,23% | 22,78 mld. | |
-10,44% | 17,96 mld. | |
-41,74% | 16,43 mld. | |
-13,31% | 16,37 mld. | |
+2,44% | 13,58 mld. | |
+27,89% | 11,66 mld. |
- Beurs
- Aandelen
- Koers GNBT
- Koers